Precision Drilling Corporation

Fundamentals6.0
Price Action4.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Below Book Value
  • Strong Cash Flow
  • Weakening Profitability

AI
AI Summary

6.0

PDS is a cash-generative but operationally leveraged recovery play—not simply a cheap contractor—where the upside hinges on upgrades translating into higher premium-rig day rates, utilization, and margins; investors should wait for clear margin recovery while prioritizing debt reduction and liquidity over buybacks if conditions soften.

MarginRecovery
CyclicalRisk
FreeCashFlow‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • •Below Book Value
  • •Strong Cash Flow
  • •Weakening Profitability

PDS trades below book value with strong cash generation and declining debt, but weakening liquidity, margin pressure, and a return to quarterly losses warrant caution.

Value
Profitability

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • •Support holding
  • •Resistance unbroken
  • •Rebound stalled

PDS remains cautiously bearish over the last month, holding $86.00–$87.00 support but needing a break above $90.50 to improve momentum.

Cautious
Bearish
Support Level: $86.00–$87.00
Resistance Level: $89.50–$90.50

Rebounded from $86.03 to $87.65 in two trading days

Sentiment & News

6.0

Key News Insights:

  • •Stronger Balance Sheet
  • •Margin Recovery
  • •Oncology Financing

Precision Drilling shows improving fundamentals and shareholder support despite margin pressure, while PDS Biotech gained funding for oncology development.

Energy
Biotech

Precision Drilling's outlook is cautiously constructive, while PDS Biotech's financing strengthens its development runway